Man Group’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$690K Sell
10,463
-1,124
-10% -$71.4K ﹤0.01% 1967
2025
Q4
$736K Buy
+11,587
New +$721K ﹤0.01% 1775
2025
Q1
Sell
-63,696
Closed -$3M 2213
2024
Q4
$3M Sell
63,696
-238,517
-79% -$12.4M 0.01% 1193
2024
Q3
$16M Buy
302,213
+227,074
+302% +$12.7M 0.05% 531
2024
Q2
$4.07M Sell
75,139
-7,505
-9% -$453K 0.01% 1094
2024
Q1
$5.79M Buy
82,644
+74,357
+897% +$5.75M 0.02% 943
2023
Q4
$692K Buy
+8,287
New +$300K ﹤0.01% 1567
2023
Q3
Sell
-244,107
Closed -$8.13M 1644
2023
Q2
$7.96M Buy
+244,107
New +$9.03M 0.02% 706
2023
Q1
Hold
0
913
2022
Q3
Hold
0
-$3.4M 2062
2022
Q2
Sell
-52,653
Closed -$2.12M 939
2022
Q1
$1.94M Buy
+52,653
New +$1.87M 0.01% 1221
2019
Q1
Sell
-11,100
Closed -$70K 1975
2018
Q4
$70K Sell
11,100
-2,300
-17% -$16.9K ﹤0.01% 1869
2018
Q3
$132K Sell
13,400
-4,900
-27% -$39.3K ﹤0.01% 2045
2018
Q2
$152K Sell
18,300
-34,200
-65% -$285K ﹤0.01% 2047
2018
Q1
$378K Buy
+52,500
New +$450K ﹤0.01% 1778

Other funds holding CYTK